Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR T790M + STRN-ALK fusion + EGFR amplification + MET amplification
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor, STRN, Striatin, Protein Phosphatase 2 Regulatory Subunit B'''Alpha, Striatin Calmodulin Binding Protein, Striatin Calmodulin-Binding Protein, PPP2R6A, SG2NA, STRN1, NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
;
238
;
4233
;
6801
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR exon 19 deletion (79)
MET amplification (66)
EGFR amplification (52)
EGFR exon 18 deletion (3)
ALK amplification (3)
MET exon 14 deletion (3)
EGFR exon 2-7 deletion + EGFR amplification (2)
EGFR amplification + ERBB2 amplification (1)
EGFR exon 19 deletion + HER-2 amplification (1)
EGFR exon 21 deletion (1)
HER-2 amplification + MET amplification (1)
MET amplification + AXL amplification (1)
EGFR T790M + exon 19 deletion (0)
EGFR amplifcation (0)
EGFR exon 19 deletion (79)
MET amplification (66)
EGFR amplification (52)
EGFR exon 18 deletion (3)
ALK amplification (3)
MET exon 14 deletion (3)
EGFR exon 2-7 deletion + EGFR amplification (2)
EGFR amplification + ERBB2 amplification (1)
EGFR exon 19 deletion + HER-2 amplification (1)
EGFR exon 21 deletion (1)
HER-2 amplification + MET amplification (1)
MET amplification + AXL amplification (1)
EGFR T790M + exon 19 deletion (0)
EGFR amplifcation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR T790M + STRN-ALK fusion + EGFR amplification + MET amplification
Non Small Cell Lung Cancer
EGFR T790M + STRN-ALK fusion + EGFR amplification + MET amplification
Non Small Cell Lung Cancer
osimertinib
Resistant: C4 – Case Studies
osimertinib
Resistant
:
C4
osimertinib
Resistant: C4 – Case Studies
osimertinib
Resistant
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.